KL Acquisition Corp is a blank check company. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses or entities. It intends to focus investment effort on life sciences, which includes medical devices, diagnostics, and life sciences tools and instrumentation. The company was incorporated in 2020 and is based in New York, New York.
IPO Year: 2021
Exchange: NASDAQ
15-12G - KL Acquisition Corp (0001823323) (Filer)
8-K/A - KL Acquisition Corp (0001823323) (Filer)
8-K - KL Acquisition Corp (0001823323) (Filer)
25-NSE - KL Acquisition Corp (0001823323) (Subject)
DEF 14A - KL Acquisition Corp (0001823323) (Filer)
10-Q - KL Acquisition Corp (0001823323) (Filer)
PRE 14A - KL Acquisition Corp (0001823323) (Filer)
NT 10-Q - KL Acquisition Corp (0001823323) (Filer)
10-Q - KL Acquisition Corp (0001823323) (Filer)
10-Q - KL Acquisition Corp (0001823323) (Filer)
This live feed shows all institutional transactions in real time.
SC 13G/A - KL Acquisition Corp (0001823323) (Subject)
SC 13G/A - KL Acquisition Corp (0001823323) (Subject)
SC 13G/A - KL Acquisition Corp (0001823323) (Subject)
SC 13G/A - KL Acquisition Corp (0001823323) (Subject)
SC 13G/A - KL Acquisition Corp (0001823323) (Subject)
SC 13G/A - KL Acquisition Corp (0001823323) (Subject)
SC 13G - KL Acquisition Corp (0001823323) (Subject)
SC 13G - KL Acquisition Corp (0001823323) (Subject)
SC 13G/A - KL Acquisition Corp (0001823323) (Subject)
SC 13G - KL Acquisition Corp (0001823323) (Subject)